HDAC-3 overexpression has been shown in glioblastoma (grade IV by definition) [31] and poorly differentiated hepatocellular [34], prostate [35,36], serous subtype of endometrial and ovarian [37] and urothelial bladder carcinoma [38]. The gene discussed is HDAC3; the disease is bladder transitional cell carcinoma.